GATAD2A Antikörper (N-Term)
-
- Target Alle GATAD2A Antikörper anzeigen
- GATAD2A (GATA Zinc Finger Domain Containing 2A (GATAD2A))
-
Bindungsspezifität
- AA 1-30, N-Term
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser GATAD2A Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB)
- Aufreinigung
- This antibody is purified through a protein A column, followed by peptide affinity purification.
- Immunogen
- This GATAD2A antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 1-30 amino acids from the N-terminal region of human GATAD2A.
- Klon
- RB42728
- Isotyp
- Ig Fraction
- Top Product
- Discover our top product GATAD2A Primärantikörper
-
-
- Applikationshinweise
- WB: 1:1000
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C,-20 °C
- Haltbarkeit
- 6 months
-
-
Knockdown of GATAD2A suppresses cell proliferation in thyroid cancer in vitro." in: Oncology reports, Vol. 37, Issue 4, pp. 2147-2152, (2017) (PubMed).
: "Human variation in alcohol response is influenced by variation in neuronal signaling genes." in: Alcoholism, clinical and experimental research, Vol. 34, Issue 5, pp. 800-12, (2010) (PubMed).
: "p66alpha and p66beta of the Mi-2/NuRD complex mediate MBD2 and histone interaction." in: Nucleic acids research, Vol. 34, Issue 2, pp. 397-406, (2006) (PubMed).
: "A probability-based approach for high-throughput protein phosphorylation analysis and site localization." in: Nature biotechnology, Vol. 24, Issue 10, pp. 1285-92, (2006) (PubMed).
: "Two highly related p66 proteins comprise a new family of potent transcriptional repressors interacting with MBD2 and MBD3." in: The Journal of biological chemistry, Vol. 277, Issue 43, pp. 40958-66, (2002) (PubMed).
: "
-
Knockdown of GATAD2A suppresses cell proliferation in thyroid cancer in vitro." in: Oncology reports, Vol. 37, Issue 4, pp. 2147-2152, (2017) (PubMed).
-
- Target
- GATAD2A (GATA Zinc Finger Domain Containing 2A (GATAD2A))
- Andere Bezeichnung
- GATAD2A (GATAD2A Produkte)
- Synonyme
- p66alpha antikoerper, GATAD2A antikoerper, 1110066C11Rik antikoerper, BC031407 antikoerper, C80248 antikoerper, RGD1310596 antikoerper, gatad2a antikoerper, ns:zf-a189 antikoerper, zgc:85938 antikoerper, GATA zinc finger domain containing 2A antikoerper, GATA zinc finger domain containing 2A L homeolog antikoerper, GATA zinc finger domain containing 2Ab antikoerper, GATAD2A antikoerper, Gatad2a antikoerper, gatad2a.L antikoerper, gatad2ab antikoerper, gatad2a antikoerper
- Hintergrund
- GATAD2A is a transcriptional repressor.
- Molekulargewicht
- 68063
- NCBI Accession
- NP_060130
- UniProt
- Q86YP4
- Pathways
- Tube Formation, Embryonic Body Morphogenesis
-